Standout Papers

Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 or... 2019 2026 2021 2023 271
  1. Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10) (2019)
    Matthew Capehorn, Andrei‐Mircea Catarig et al. Diabetes & Metabolism

Immediate Impact

3 from Science/Nature 83 standout
Sub-graph 1 of 23

Citing Papers

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Adipose tissue retains an epigenetic memory of obesity after weight loss
2024 StandoutNature
2 intermediate papers

Works of Andrei‐Mircea Catarig being referenced

An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg
2021
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
2019 Standout

Author Peers

Author Last Decade Papers Cites
Andrei‐Mircea Catarig 825 581 160 219 29 917
Steen H. Ingwersen 605 351 227 110 30 852
Takeshi Imaoka 769 436 247 208 50 1.2k
Jeffrey Unger 711 363 194 161 14 817
P. Miossec 971 446 372 201 22 1.1k
Thomas Hach 816 500 434 180 37 1.1k
Zin Zin Htike 764 350 269 177 14 877
Yoshishige Samukawa 736 386 328 134 25 888
Slobodan Antić 833 456 284 196 33 1.1k
Ioannis Avgerinos 820 386 261 213 28 985
Bipin Sethi 907 470 299 195 39 1.1k

All Works

Loading papers...

Rankless by CCL
2026